North America Direct to consumer DNA Testing Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
North America Direct to consumer DNA Testing Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
North America Direct to consumer DNA Testing Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| North America Direct to consumer DNA Testing Total | xxxx | xxxx | xxxx | 23.2% |
| United States | xxxx | xxxx | xxxx | xxxx |
| Canada | xxxx | xxxx | xxxx | xxxx |
| Mexico | xxxx | xxxx | xxxx | xxxx |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Test Type breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Direct to consumer DNA Testing Market
The Direct-to-Consumer (DTC) Genetic Testing Market competitive landscape provides details of a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance.
Direct to consumer DNA Testing Industry News
For instance, in February 2022, Invitae Corporation announced the launch of its new genetic testing kits for cancer diagnosis, LiquidPlex Dx and FusionPlex Dx, in Europe.
For instance, in February 2023, the NIH researchers launched an innovative software, Verkko, which is capable of assembling the complete genome sequence more easily and economically. Moreover, the increase in cancer-causing mutations further boosts the whole genome sequencing segment.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Direct to consumer DNA Testing Market size was estimated at USD 2151.2 Million, out of which North America is the major market with more than 40% of the global revenue with a market size of USD 860.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.2% from 2024 to 2031. The market's success in North America is attributed to a combination of factors, including a tech-savvy population, cultural curiosity about ancestry, and an increasing focus on proactive healthcare. The Carrier Testing segment within the Direct-to-Consumer (DTC) DNA testing market focuses on identifying individuals carrying genetic mutations associated with inherited disorders. This specialized service offers prospective parents valuable insights into the risk of passing on specific genetic conditions to their offspring. In conclusion, the North American DTC DNA Testing market continues to thrive, reflecting a dynamic interplay between consumer interest, technological advancements, and evolving regulatory landscapes.
Country Analysis
- According to Cognitive Market Research, the US had a major share in the direct-to-consumer DNA Testing Market, with a market size of USD 678.92 million in 2024, which is projected to grow at a CAGR of 7.8% during the forecast period. The USA market remains dynamic, with ongoing product innovations and adaptations to cater to the diverse needs of outdoor enthusiasts.
- The Canadian IT peripheral markets market had a market share of USD 103.26 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. The Canadian market remains dynamic, with ongoing product innovations addressing consumer needs and safety standards.
- The Mexico IT peripheral markets market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 78.30 million in 2024.
The Service & Software industry is rapidly growing, driven by cloud computing, AI automation, digital transformation, and remote work. While the North America Direct to consumer DNA Testing Market Analysis market faces challenges like data security, integration issues, and changing consumer needs, it also offers strong opportunities through emerging markets and tech breakthroughs. Key trends include digital adoption, sustainability, and environmental focus, enabling businesses to stay competitive and achieve sustainable growth.
Analyst Conclusion
- Author Says: North America held the major market with more than 40% of the global revenue with a market size of USD 860.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.2% from 2024 to 2031.
- The Carrier Testing market witnesses steady growth due to increased awareness of genetic health risks, advancements in genetic research, and a growing trend toward proactive healthcare decision-making among individuals and couples planning to start a family.
- The Predictive Testing segment within the Direct-to-Consumer (DTC) DNA testing market focuses on offering individuals insights into their genetic predispositions for various health conditions. Companies like 23andMe and AncestryDNA provide predictive testing services that analyze DNA for markers associated with conditions such as Alzheimer's disease, cardiovascular disorders, and certain cancers.
Driven by a passion for transforming complex digital and business data into actionable market intelligence, Aarti Bagekari focuses her research expertise on the Services & Software and Internet & Communication sectors. Her professional interests lie in analyzing evolving technology ecosystems, digital business models, software innovation, communication infrastructure, and emerging trends that are reshaping the global digital economy.
By leveraging a combination of primary and secondary research methodologies, Aarti develops comprehensive market perspectives that enable organizations to make informed strategic decisions in highly dynamic and competitive environments. Her work involves engaging with industry experts, technology providers, service operators, and key stakeholders while conducting extensive analysis of market data, industry developments, regulatory landscapes, and competitive dynamics. This balanced research approach allows her to uncover meaningful market patterns and identify opportunities that support long-term business growth.
Aarti possesses strong capabilities in market sizing and forecasting, competitive benchmarking, customer and stakeholder research, technology trend analysis, and strategic market assessment. She regularly evaluates developments across software solutions, cloud computing, digital services, telecommunications, internet platforms, enterprise technologies, and next-generation communication networks. Her ability to synthesize large volumes of information into clear and actionable insights helps organizations better understand market shifts, customer expectations, and emerging business opportunities.
At Cognitive Market Research & Consulting, Aarti contributes to market research reports, custom consulting engagements, and survey-based studies that support technology vendors, service providers, investors, and enterprise decision-makers. Her analytical mindset, attention to detail, and commitment to research excellence enable clients to navigate rapidly evolving digital markets, strengthen competitive positioning, and develop sustainable growth strategies in an increasingly connected world.
Frequently Asked Questions
★ Reviews
Rate this report
North America Direct to consumer DNA Testing Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Test Type | Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Utrigenomics Testing, Others |
|---|---|
| Technology | Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS) |
| Sales Channel | Online Sales, OTC Sales |
| End User | Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics, Others |
| List of Competitors | 23andMe, Family Tree DNA, Ancestry, Genesis HealthCare, EasyDNA, Veritas, Myriad Genetics Inc, Full Genomes Corporation Inc, Living DNA Ltd, Color Health Inc |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 23andMe
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 Family Tree DNA
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 Ancestry
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Genesis HealthCare
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 EasyDNA
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 Veritas
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 Myriad Genetics Inc
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Full Genomes Corporation Inc
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 Living DNA Ltd
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.10 Color Health Inc
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 R&D Investment (Subject to data availability)
- 1.2.10.4 Financials (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
- 1.2.1 23andMe
- 1.1 Top Competitors Analysis
Chapter 2. Global Direct to consumer DNA Testing Market Analysis
- 2.1 Global Direct to consumer DNA Testing Market Analysis
- 2.2 Global Direct to consumer DNA Testing Market Analysis by Test Type
- 2.3 Global Direct to consumer DNA Testing Market Analysis by Technology
- 2.4 Global Direct to consumer DNA Testing Market Analysis by Sales Channel
- 2.5 Global Direct to consumer DNA Testing Market Analysis by End User
Chapter 3. North America Direct to consumer DNA Testing Market Analysis
- 3.1 North America Direct to consumer DNA Testing Market Analysis
- 3.2 North America Direct to consumer DNA Testing Market Analysis by Country
- 3.3 North America Direct to consumer DNA Testing Market Analysis by Test Type
- 3.4 North America Direct to consumer DNA Testing Market Analysis by Technology
- 3.5 North America Direct to consumer DNA Testing Market Analysis by Sales Channel
- 3.6 North America Direct to consumer DNA Testing Market Analysis by End User
- 3.7 North America Direct to consumer DNA Testing Market Analysis by Key Players
Chapter 4. United States Direct to consumer DNA Testing Market Analysis
- 4.1 United States Direct to consumer DNA Testing Market Analysis
- 4.2 United States Direct to consumer DNA Testing Market Analysis by Test Type
- 4.3 United States Direct to consumer DNA Testing Market Analysis by Technology
- 4.4 United States Direct to consumer DNA Testing Market Analysis by Sales Channel
- 4.5 United States Direct to consumer DNA Testing Market Analysis by End User
- 4.6 United States Direct to consumer DNA Testing Market Analysis by Key Players
Chapter 5. Canada Direct to consumer DNA Testing Market Analysis
- 5.1 Canada Direct to consumer DNA Testing Market Analysis
- 5.2 Canada Direct to consumer DNA Testing Market Analysis by Test Type
- 5.3 Canada Direct to consumer DNA Testing Market Analysis by Technology
- 5.4 Canada Direct to consumer DNA Testing Market Analysis by Sales Channel
- 5.5 Canada Direct to consumer DNA Testing Market Analysis by End User
- 5.6 Canada Direct to consumer DNA Testing Market Analysis by Key Players
Chapter 6. Mexico Direct to consumer DNA Testing Market Analysis
- 6.1 Mexico Direct to consumer DNA Testing Market Analysis
- 6.2 Mexico Direct to consumer DNA Testing Market Analysis by Test Type
- 6.3 Mexico Direct to consumer DNA Testing Market Analysis by Technology
- 6.4 Mexico Direct to consumer DNA Testing Market Analysis by Sales Channel
- 6.5 Mexico Direct to consumer DNA Testing Market Analysis by End User
- 6.6 Mexico Direct to consumer DNA Testing Market Analysis by Key Players
Chapter 7. Test Type Analysis
- 7.1 Carrier Testing
- 7.2 Predictive Testing
- 7.3 Ancestry and Relationship Testing
- 7.4 Utrigenomics Testing
- 7.5 Others
Chapter 8. Technology Analysis
- 8.1 Targeted Analysis
- 8.2 Single Nucleotide Polymorphism (SNP) Chips
- 8.3 Whole Genome Sequencing (WGS)
Chapter 9. Sales Channel Analysis
- 9.1 Online Sales
- 9.2 OTC Sales
Chapter 10. End User Analysis
- 10.1 Laboratories
- 10.2 Blood Banks
- 10.3 Nursing Homes
- 10.4 Hospitals
- 10.5 Imaging Centres
- 10.6 Home Care
- 10.7 Cosmetics
- 10.8 Others
Chapter 11. Qualitative Analysis (Subject to Data Availability)
- 11.1 Market Drivers
- 11.2 Market Restraints
- 11.3 Market Trends
- 11.4 Market Opportunity
- 11.5 Technological Road Map (Subject to Data Availability)
- 11.6 Product Life Cycle (Subject to Data Availability)
- 11.7 Customer and Buyer Behavior Analysis
- 11.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 11.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 11.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 11.7.4 Pricing, Affordability & Value Perception Analysis
- 11.7.5 Customer Segmentation & Demand Pattern Analysis
- 11.8 Industrial Chain Analysis (Subject to Data Availability)
- 11.8.1 Industry Chain Analysis
- 11.8.2 Manufacturing Cost Analysis
- 11.8.3 Supply Side Analysis
- 11.8.3.1 Raw Material Analysis
- 11.8.3.2 Raw Material Procurement Analysis
- 11.8.3.3 Raw Material Price Trend Analysis
- 11.9 PESTEL Analysis
- 11.9.1 Environmental Factors
- 11.9.2 Legal Factors
- 11.9.3 Technological Factors
- 11.9.4 Economic Factors
- 11.9.5 Political Factors
- 11.9.6 Social Factors
- 11.10 Porter’s Five Forces Analysis
- 11.10.1 Degree of Competition
- 11.10.2 Threat of Substitutes
- 11.10.3 Threat of New Entrants
- 11.10.4 Bargaining Power of Buyers
- 11.10.5 Bargaining Power of Suppliers
- 11.11 Patent Analysis (Subject to Data Availability)
- 11.12 ESG Analysis
- 11.13 Geopolitical Outlook
- 11.13.1 Global Power Realignment & Strategic Alliances
- 11.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 11.13.3 International Trade Relations & Market Access Environment
- 11.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 11.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 11.13.6 Technology Sovereignty & Digital Geopolitics
- 11.13.7 Strategic Implications for Investment, Growth & Market Entry
- 11.14 AI & Market Transformation
- 11.14.1 Competitive Landscape Disruption & Strategic Shifts
- 11.14.2 AI-Driven Transformation of Industry Value Chain
- 11.14.3 Evolution of Business Models & Revenue Streams
- 11.14.4 AI-Driven Product, Service & Innovation Transformation
- 11.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 12. Research Findings
- 12.1 Key Takeaways
- 12.2 Analyst Point of View
- 12.3 Assumptions and Acronyms
Chapter 13. Research Methodology and Sources
- 13.1 Primary Data Collection
- 13.1.1 Steps for Primary Data Collection
- 13.1.1.1 Identification of KOL
- 13.1.2 Backward Integration
- 13.1.3 Forward Integration
- 13.1.4 How Primary Research Help Us
- 13.1.5 Modes of Primary Research
- 13.1.1 Steps for Primary Data Collection
- 13.2 Secondary Research
- 13.2.1 How Secondary Research Help Us
- 13.2.2 Sources of Secondary Research
- 13.3 Data Validation
- 13.3.1 Data Triangulation
- 13.4 Data Representation
- 13.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Aarti Bagekari and team for the North America Direct to consumer DNA Testing Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Service and Software Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the North America Direct to consumer DNA Testing Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the north america direct to consumer dna testing market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
